FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1970374211> ?p ?o ?g. }

• W1970374211 endingPage "526" @default.
• W1970374211 startingPage "513" @default.
• W1970374211 abstract "Background The comparative efficacy and tolerability of conventional and biologic treatments for moderate‐to‐severe plaque psoriasis are unknown. Objectives To perform a systematic review and meta‐analysis of randomized controlled trials (RCTs) reporting efficacy of systemic treatments approved for moderate‐to‐severe psoriasis by means of the Psoriasis Area and Severity Index (PASI). Methods We identified relevant articles by systematic electronic searches (Cochrane Library, Medline, Embase, Scopus). Efficacy was defined as proportion of participants with ≥ 75% decrease in PASI (PASI‐75) at primary efficacy measurement (week 8–16). PASI‐75 response rates of double‐blind placebo‐controlled trials were summarized as risk differences (RDs) and pooled using random effects models. Tolerability was assessed from rates of withdrawals and adverse events. Results Twenty‐four RCTs totalling 9384 patients were analysed qualitatively. Sixteen double‐blind placebo‐controlled trials were eligible for meta‐analysis. Infliximab was significantly superior to all other interventions [RD 77%, 95% confidence interval (CI) 72–81%]. Adalimumab (RD 64%, 95% CI 61–68%) was superior to ciclosporin (RD 33%, 95% CI 13–52%), efalizumab (RD 24%, 95% CI 19–30%), etanercept 50 mg twice weekly (RD 44%, 95% CI 40–48%) and etanercept 25 mg twice weekly (RD 30%, 95% CI 25–35%). Efalizumab was significantly less efficacious than fumaric acid esters (RD 48%, 95% CI 32–64%). Rates of withdrawals due to adverse events were highest for methotrexate and fumaric acid esters. Conclusions The efficacy of systemic agents approved for moderate‐to‐severe psoriasis differs considerably both within and between biologics and nonbiologics. Infliximab is most efficacious, followed by adalimumab. Patients receiving infliximab have an excess chance of 77% over placebo to achieve PASI‐75 response. Published evidence questions regulatory guidelines that recommend biologics as second‐line therapy for moderate‐to‐severe plaque psoriasis." @default.
• W1970374211 created "2016-06-24" @default.
• W1970374211 creator A5035870769 @default.
• W1970374211 creator A5044349612 @default.
• W1970374211 creator A5053155088 @default.
• W1970374211 creator A5082805795 @default.
• W1970374211 creator A5086678654 @default.
• W1970374211 date "2008-09-01" @default.
• W1970374211 modified "2023-10-06" @default.
• W1970374211 title "Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials" @default.
• W1970374211 cites W1600222105 @default.
• W1970374211 cites W1969368658 @default.
• W1970374211 cites W1969546360 @default.
• W1970374211 cites W1973443311 @default.
• W1970374211 cites W1975162362 @default.
• W1970374211 cites W1975463338 @default.
• W1970374211 cites W1975900036 @default.
• W1970374211 cites W1981824867 @default.
• W1970374211 cites W1982197356 @default.
• W1970374211 cites W1985951317 @default.
• W1970374211 cites W1986215651 @default.
• W1970374211 cites W1988021062 @default.
• W1970374211 cites W1990174229 @default.
• W1970374211 cites W1991068078 @default.
• W1970374211 cites W1991234845 @default.
• W1970374211 cites W1996773947 @default.
• W1970374211 cites W2000893573 @default.
• W1970374211 cites W2002734145 @default.
• W1970374211 cites W2012581664 @default.
• W1970374211 cites W2013361256 @default.
• W1970374211 cites W2013748954 @default.
• W1970374211 cites W2019276276 @default.
• W1970374211 cites W2019947683 @default.
• W1970374211 cites W2022665587 @default.
• W1970374211 cites W2024814916 @default.
• W1970374211 cites W2027941153 @default.
• W1970374211 cites W2028656318 @default.
• W1970374211 cites W2030348118 @default.
• W1970374211 cites W2034585843 @default.
• W1970374211 cites W2034992158 @default.
• W1970374211 cites W2036488279 @default.
• W1970374211 cites W2053906912 @default.
• W1970374211 cites W2055018575 @default.
• W1970374211 cites W2060546762 @default.
• W1970374211 cites W2063627867 @default.
• W1970374211 cites W2067327580 @default.
• W1970374211 cites W2086861262 @default.
• W1970374211 cites W2091442391 @default.
• W1970374211 cites W2093116261 @default.
• W1970374211 cites W2096991001 @default.
• W1970374211 cites W2098835966 @default.
• W1970374211 cites W2107722406 @default.
• W1970374211 cites W2113750014 @default.
• W1970374211 cites W2121126920 @default.
• W1970374211 cites W2129137973 @default.
• W1970374211 cites W2129412675 @default.
• W1970374211 cites W2134206785 @default.
• W1970374211 cites W2138138193 @default.
• W1970374211 cites W2138763209 @default.
• W1970374211 cites W2146843653 @default.
• W1970374211 cites W2152976783 @default.
• W1970374211 cites W2163232748 @default.
• W1970374211 cites W2164218337 @default.
• W1970374211 cites W2164533070 @default.
• W1970374211 cites W2168503185 @default.
• W1970374211 cites W2168911501 @default.
• W1970374211 cites W2169787227 @default.
• W1970374211 cites W2170270641 @default.
• W1970374211 cites W2172257129 @default.
• W1970374211 cites W2416464647 @default.
• W1970374211 cites W4292806894 @default.
• W1970374211 doi "https://doi.org/10.1111/j.1365-2133.2008.08732.x" @default.
• W1970374211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18627372" @default.
• W1970374211 hasPublicationYear "2008" @default.
• W1970374211 type Work @default.
• W1970374211 sameAs 1970374211 @default.
• W1970374211 citedByCount "177" @default.
• W1970374211 countsByYear W19703742112012 @default.
• W1970374211 countsByYear W19703742112013 @default.
• W1970374211 countsByYear W19703742112014 @default.
• W1970374211 countsByYear W19703742112015 @default.
• W1970374211 countsByYear W19703742112016 @default.
• W1970374211 countsByYear W19703742112017 @default.
• W1970374211 countsByYear W19703742112018 @default.
• W1970374211 countsByYear W19703742112020 @default.
• W1970374211 countsByYear W19703742112021 @default.
• W1970374211 countsByYear W19703742112022 @default.
• W1970374211 countsByYear W19703742112023 @default.
• W1970374211 crossrefType "journal-article" @default.
• W1970374211 hasAuthorship W1970374211A5035870769 @default.
• W1970374211 hasAuthorship W1970374211A5044349612 @default.
• W1970374211 hasAuthorship W1970374211A5053155088 @default.
• W1970374211 hasAuthorship W1970374211A5082805795 @default.
• W1970374211 hasAuthorship W1970374211A5086678654 @default.
• W1970374211 hasConcept C126322002 @default.
• W1970374211 hasConcept C142724271 @default.
• W1970374211 hasConcept C16005928 @default.
• W1970374211 hasConcept C168563851 @default.

• next